Vaccination against seasonal influenza is effective in Japanese patients with rheumatoid arthritis enrolled in a large observational cohort

References

• Lacaille D, Guh DP, Abrahamowicz M, Anis AH, Esdaile JM. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis. Arthritis Rheum 2008;59:1074–81.
   PubMed Web of Science ®Google Scholar
• Doran MF, Crowson CS, Pond GR, O’Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002;46:2287–93.
   PubMed Web of Science ®Google Scholar
• Symmons DP, Jones MA, Scott DL, Prior P. Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol 1998;25:1072–7.
   PubMed Web of Science ®Google Scholar
• Bjornadal L, Baecklund E, Yin L, Granath F, Klareskog L, Ekbom A. Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95. J Rheumatol 2002;29:906–12.
   PubMed Web of Science ®Google Scholar
• Nakajima A, Inoue E, Tanaka E, Singh G, Sato E, Hoshi D, Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA. Scand J Rheumatol 2010;39:360–7.
   PubMed Web of Science ®Google Scholar
• Franklin J, Lunt M, Bunn D, Symmons D, Silman A. Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis. Ann Rheum Dis 2007;66:308–12.
   PubMed Web of Science ®Google Scholar
• Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2006;54:2368–76.
   PubMed Web of Science ®Google Scholar
• van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2011;70:414–22.
   PubMed Web of Science ®Google Scholar
• Brezinschek HP, Hofstaetter T, Leeb BF, Haindl P, Graninger WB. Immunization of patients with rheumatoid arthritis with antitumor necrosis factor alpha therapy and methotrexate. Curr Opin Rheumatol 2008;20:295–9.
   Google Scholar
• Gluck T. Vaccinate your immunocompromised patients! Rheumatology (Oxford) 2006;45:9–10.
   Google Scholar
• Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995;123:518–27.
   PubMed Web of Science ®Google Scholar
• Ortqvist A, Granath F, Askling J, Hedlund J. Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area. Eur Respir J 2007;30:414–22.
   PubMed Web of Science ®Google Scholar
• Blank PR, Schwenkglenks M, Szucs TD. Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health 2008;8:272.
   PubMed Web of Science ®Google Scholar
• Chalmers A, Scheifele D, Patterson C, Williams D, Weber J, Shuckett R, Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol 1994;21:1203–6.
   PubMed Web of Science ®Google Scholar
• Fomin I, Caspi D, Levy V, Varsano N, Shalev Y, Paran D, Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis 2006;65:191–4.
   PubMed Web of Science ®Google Scholar
• Kaine JL, Kivitz AJ, Birbara C, Luo AY. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol 2007;34:272–9.
   PubMed Web of Science ®Google Scholar
• Kapetanovic MC, Saxne T, Nilsson JA, Geborek P. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology (Oxford) 2007;46:608–11.
   PubMed Web of Science ®Google Scholar
• Gelinck LB, van der Bijl AE, Beyer WE, Visser LG, Huizinga TW, van Hogezand RA, The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis 2008;67:713–16.
   PubMed Web of Science ®Google Scholar
• Yamanaka H, Seto Y, Tanaka E, Furuya T, Nakajima A, Ikari K, Management of rheumatoid arthritis: the 2012 perspective. Mod Rheumatol 2013;23:1–7.
   PubMed Web of Science ®Google Scholar
• Yamanaka H, Inoue E, Singh G, Tanaka E, Nakajima A, Taniguchi A, Improvement of disease activity of rheumatoid arthritis patients from 2000 to 2006 in a large observational cohort study IORRA in Japan. Mod Rheumatol 2007;17:283–9.
   PubMedGoogle Scholar
• Nakajima A, Inoue E, Shidara K, Hoshi D, Sato E, Seto Y, Standard treatment in daily clinical practice for early rheumatoid arthritis improved disease activity from 2001 to 2006. Mod Rheumatol 2011;21:594–7.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Matsuda Y, Singh G, Yamanaka H, Tanaka E, Urano W, Taniguchi A, Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3,763 patients with rheumatoid arthritis. Arthritis Rheum 2003;49:784–8.
   PubMed Web of Science ®Google Scholar
• Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38: 44–8.
   PubMed Web of Science ®Google Scholar
• Au:Refs 25–28: title of article in English please?Kawai N, Ikematsu H, Iwaki N, Maeda T, Satoh I, Kawashima T, et al. Japan Med J 2008;4381:72–7.
   Google Scholar
• Kawai N, Iwaki N, Komatsu M, Satoh I, Akimoto H, Kondo K, Japan Med J 2001;4044:23–30.
   Google Scholar
• Kawai N, Iwaki N, Shigematsu T, Satoh I, Kawashima T, Kondo K, Japan Med J 2002;4104:16–24.
   Google Scholar
• Kawai N, Ikematsu H, Iwaki N, Miyachi K, Shigematsu T, Satoh I, Japan Med J 2003;4144:24–31.
   Google Scholar
• Kawai N, Ikematsu H, Iwaki N, Satoh I, Kawashima T, Tsuchimoto T, A prospective, Internet-based study of the effectiveness and safety of influenza vaccination in the 2001-2002 influenza season. Vaccine 2003;21:4507–13.
   PubMed Web of Science ®Google Scholar
• Herron A, Dettleff G, Hixon B, Brandwin L, Ortbals D, Hornick R, Influenza vaccination in patients with rheumatic diseases. Safety and efficacy. J Am Med Assoc 1979;242:53–6.
   PubMed Web of Science ®Google Scholar
• Salemi S, Picchianti-Diamanti A, Germano V, Donatelli I, Di Martino A, Facchini M, Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity. Clin Immunol 2010;134: 113–20.
   PubMed Web of Science ®Google Scholar
• Ribeiro AC, Guedes LK, Moraes JC, Saad CG, Aikawa NE, Calich AL, Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice. Ann Rheum Dis 2011;70:2144–7.
   PubMed Web of Science ®Google Scholar
• Finsterer J, Artner C, Kladosek A, Kalchmayr R, Redtenbacher S. Cavernous sinus syndrome due to vaccination-induced giant cell arteritis. Arch Intern Med 2001;161:1008–9.
   Google Scholar
• Iyngkaran P, Limaye V, Hill C, Henderson D, Pile KD, Rischmueller M. Rheumatoid vasculitis following influenza vaccination. Rheumatology (Oxford) 2003;42:907–9.
   Google Scholar